Items 471 to 480 of 500 total
Schermo:
Nome del prodotto | CAS # | Codice del prodotto | Quantità | Prezzo | CITAZIONI | Valutazione |
---|---|---|---|---|---|---|
Heptakis(6-O-sulfo)-β-cyclodextrin Tetradecaacetate Heptapyridium Salt | 196398-65-9 | sc-211583 | 250 mg | $340.00 | ||
Heptakis(6-O-sulfo)-β-cyclodextrin Tetradecaacetate Heptapyridium Salt is A component contained in cosmetic formulation. Diesters of glycosylglycerols are active in cancer chemo-prevention. | ||||||
5-Hydroxy Desloratadine | 117811-12-8 | sc-210328 | 1 mg | $400.00 | ||
5-Hydroxy Desloratadine è un metabolita idrossilato della Desloratadina | ||||||
Hydroxydehydro Nifedipine Carboxylate | 34783-31-8 | sc-211614 | 1 mg | $380.00 | ||
Hydroxydehydro Nifedipine Carboxylate is a main metabolite of Nifedipine | ||||||
Hydroxy Pioglitazone (M-II) | 101931-00-4 | sc-211608 | 1 mg | $305.00 | 1 | |
Hydroxy Pioglitazone (M-II) is a metabolite of Pioglitazone | ||||||
5-Hydroxy Rosiglitazone Sulfate | 288853-63-4 | sc-210334 | 1 mg | $380.00 | ||
5-Hydroxy Rosiglitazone Sulfate è un metabolita del Rosiglitazone | ||||||
4-(Methylamino)-1-(3-pyridyl-d4)-1-butanone Dihydrochloride | 764661-23-6 | sc-209850 | 5 mg | $380.00 | ||
4-(Methylamino)-1-(3-pyridyl-d4)-1-butanone Dihydrochloride is a precursor to NNK and an amino ketone metabolite | ||||||
5-Methoxypyridine-3-boronic acid | 850991-69-4 | sc-262651 sc-262651A | 1 g 5 g | $174.00 $693.00 | ||
5-Methoxypyridine-3-boronic acid is a boronic acid substituted pyridine compound for proteomics research | ||||||
(2-Aminopyridin-3-yl)methanol | 23612-57-9 | sc-206401 | 5 g | $192.00 | ||
(2-Aminopyridin-3-yl)methanol è un derivato piridinico per la ricerca proteomica | ||||||
Nitenpyram | 150824-47-8 | sc-228837 | 100 mg | $103.00 | 2 | |
Nitenpyram è un insetticida cloronicotinile principalmente contro le mosche come adulticida | ||||||
2-Ethoxynicotinic acid | 35969-54-1 | sc-259803 sc-259803A | 10 g 25 g | $27.00 $117.00 | ||
2-Ethoxynicotinic acid is compound that is derived from niacin (vitamin B3) |